FER and FES tyrosine kinase fusions in follicular T-cell lymphoma. 2020

Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
Center for Cancer Biology, Vlaams Instituut voor Biotechnologie, Leuven, Belgium.

UI MeSH Term Description Entries
D008224 Lymphoma, Follicular Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES. Brill-Symmers Disease,Follicular Lymphoma,Lymphoma, Giant Follicular,Lymphoma, Nodular,Follicular Large-Cell Lymphoma,Follicular Lymphoma, Giant,Follicular Lymphoma, Grade 1,Follicular Lymphoma, Grade 2,Follicular Lymphoma, Grade 3,Follicular Mixed-Cell Lymphoma,Giant Follicular Lymphoma,Histiocytic Lymphoma, Nodular,Large Lymphoid Lymphoma, Nodular,Large-Cell Lymphoma, Follicular,Lymphocytic Lymphoma, Nodular, Poorly Differentiated,Lymphocytic Lymphoma, Nodular, Poorly-Differentiated,Lymphoma, Follicular Large-Cell,Lymphoma, Follicular, Grade 1,Lymphoma, Follicular, Grade 2,Lymphoma, Follicular, Grade 3,Lymphoma, Follicular, Mixed Cell,Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic,Lymphoma, Follicular, Mixed Small and Large Lymphoid,Lymphoma, Follicular, Small and Large Cleaved Cell,Lymphoma, Follicular, Small and Large Cleaved-Cell,Lymphoma, Histiocytic, Nodular,Lymphoma, Large Cell, Follicular,Lymphoma, Large Lymphoid, Nodular,Lymphoma, Large-Cell, Follicular,Lymphoma, Lymphocytic, Nodular, Poorly Differentiated,Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated,Lymphoma, Mixed-Cell, Follicular,Lymphoma, Nodular, Large Follicular Center Cell,Lymphoma, Nodular, Large Follicular Center-Cell,Lymphoma, Nodular, Mixed Lymphocytic Histiocytic,Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic,Lymphoma, Nodular, Mixed Small and Large Cell,Lymphoma, Small Cleaved Cell, Follicular,Lymphoma, Small Cleaved-Cell, Follicular,Lymphoma, Small Follicular Center-Cell,Lymphoma, Small Lymphoid, Follicular,Mixed-Cell Lymphoma, Follicular,Nodular Large Follicular Center-Cell Lymphoma,Small Cleaved-Cell Lymphoma, Follicular,Small Follicular Center-Cell Lymphoma,Brill Symmers Disease,Disease, Brill-Symmers,Follicular Large Cell Lymphoma,Follicular Large-Cell Lymphomas,Follicular Lymphomas,Follicular Lymphomas, Giant,Follicular Mixed Cell Lymphoma,Follicular Mixed-Cell Lymphomas,Giant Follicular Lymphomas,Histiocytic Lymphomas, Nodular,Large Cell Lymphoma, Follicular,Large-Cell Lymphomas, Follicular,Lymphoma, Follicular Large Cell,Lymphoma, Follicular Mixed-Cell,Lymphoma, Nodular Histiocytic,Lymphoma, Small Follicular Center Cell,Lymphomas, Follicular,Lymphomas, Follicular Large-Cell,Lymphomas, Follicular Mixed-Cell,Lymphomas, Giant Follicular,Lymphomas, Nodular,Lymphomas, Nodular Histiocytic,Mixed Cell Lymphoma, Follicular,Mixed-Cell Lymphomas, Follicular,Nodular Histiocytic Lymphoma,Nodular Histiocytic Lymphomas,Nodular Large Follicular Center Cell Lymphoma,Nodular Lymphoma,Nodular Lymphomas,Small Cleaved Cell Lymphoma, Follicular,Small Follicular Center Cell Lymphoma
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old
D015514 Oncogene Proteins, Fusion The GENETIC TRANSLATION products of the fusion between an ONCOGENE and another gene. The latter may be of viral or cellular origin. Chimeric Oncogene Proteins,Chimeric Proteins, Oncogene,Fusion Proteins, Oncogene,Oncogene Fusion Proteins,Oncogene Proteins, Chimeric,Fusion Oncogene Proteins,Oncogene Chimeric Proteins,Proteins, Chimeric Oncogene,Proteins, Fusion Oncogene,Proteins, Oncogene Chimeric,Proteins, Oncogene Fusion
D016399 Lymphoma, T-Cell A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes. T-Cell Lymphoma,Lymphoma, T Cell,Lymphomas, T-Cell,T Cell Lymphoma,T-Cell Lymphomas
D050596 Oncogene Fusion The GENETIC RECOMBINATION of the parts of two or more GENES, including an ONCOGENE as at least one of the fusion partners. Such gene fusions are often detected in neoplastic cells and are transcribed into ONCOGENE FUSION PROTEINS. Oncogene Fusions
D051578 Proto-Oncogene Proteins c-fes Proto-oncogene proteins fes are protein-tyrosine kinases with a central SH2 DOMAIN. It has been implicated in SIGNAL TRANSDUCTION PATHWAYS for CELL DIFFERENTIATION of a variety of cell types including MYELOID PROGENITOR CELLS. Fes proto-oncogene proteins also bind TUBULIN and promote MICROTUBULE assembly. c-fes Proteins,fes Proto-Oncogene Proteins,fps Proto-Oncogene Protein,Feline Sarcoma Proto-Oncogene Protein,Proto-Oncogene Protein c-fes,Proto-Oncogene Protein fes,c-fes Proto-Oncogene Proteins,c-fes Tyrosine Kinase,Feline Sarcoma Proto Oncogene Protein,Kinase, c-fes Tyrosine,Proteins, c-fes,Proto Oncogene Protein c fes,Proto Oncogene Protein fes,Proto Oncogene Proteins c fes,Proto-Oncogene Protein, fps,Proto-Oncogene Proteins, c-fes,Proto-Oncogene Proteins, fes,Tyrosine Kinase, c-fes,c fes Proteins,c fes Proto Oncogene Proteins,c fes Tyrosine Kinase,c-fes, Proto-Oncogene Protein,c-fes, Proto-Oncogene Proteins,fes Proto Oncogene Proteins,fes, Proto-Oncogene Protein,fps Proto Oncogene Protein

Related Publications

Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
January 2012, Frontiers in bioscience (Landmark edition),
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
October 1998, Molecular and cellular biology,
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
August 2006, Development (Cambridge, England),
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
February 2018, Leukemia,
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
January 2000, Molecular and cellular endocrinology,
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
January 2021, Journal of cancer research and therapeutics,
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
September 2016, Blood,
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
November 2023, Pathologie (Heidelberg, Germany),
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
August 2013, Molecular cancer research : MCR,
Koen Debackere, and Jo-Anne van der Krogt, and Thomas Tousseyn, and Julio Antonio Finalet Ferreiro, and Katrien Van Roosbroeck, and Lukas Marcelis, and Carlos Graux, and Daan Dierickx, and Geneviève Ameye, and Peter Vandenberghe, and Lucienne Michaux, and Jan Cools, and Iwona Wlodarska
December 1989, Molecular and cellular biology,
Copied contents to your clipboard!